{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:55:30Z","timestamp":1782561330061,"version":"3.54.5"},"reference-count":61,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation (NRF), The Republic of Korea","award":["2014R1A2A1A11054432, NRF-2017M3A9C8027975, and NRF-2018R1D1A1B07048830"],"award-info":[{"award-number":["2014R1A2A1A11054432, NRF-2017M3A9C8027975, and NRF-2018R1D1A1B07048830"]}]},{"name":"Research Fund of Hanyang University","award":["HY-2018"],"award-info":[{"award-number":["HY-2018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Murine erythroleukemia (MEL) cells are often employed as a model to dissect mechanisms of erythropoiesis and erythroleukemia in vitro. Here, an allograft model using MEL cells resulting in splenomegaly was established to develop a diagnostic model for isolation\/quantification of metastatic cells, anti-cancer drug screening, and evaluation of the tumorigenic or metastatic potentials of molecules in vivo. In this animal model, circulating MEL cells from the blood stream were successfully isolated and quantified with an additional in vitro cultivation step. In terms of the molecular-pathological analysis, we were able to successfully evaluate the functional discrimination between methyl-CpG-binding domain 2 (Mbd2) and p66\u03b1 in erythroid differentiation, and tumorigenic potential in spleen and blood stream of allograft model mice. In addition, we found that the number of circulating MEL cells in anti-cancer drug-treated mice was dose-dependently decreased. Our data demonstrate that the newly established allograft model is useful to dissect erythroleukemia pathologies and non-invasively provides valuable means for isolation of metastatic cells, screening of anti-cancer drugs, and evaluation of the tumorigenic potentials.<\/jats:p>","DOI":"10.3390\/cancers11111707","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T12:30:50Z","timestamp":1572611450000},"page":"1707","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research"],"prefix":"10.3390","volume":"11","author":[{"given":"Min Young","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwoo","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seol Eui","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"},{"name":"Department of Clinical Pathology, Hanyang University Seoul Hospital, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Han","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Animal Science &amp; Technology, Chung-Ang University, Ansung, Gyeonggi-do 17546, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buom-Yong","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Animal Science &amp; Technology, Chung-Ang University, Ansung, Gyeonggi-do 17546, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-5857","authenticated-orcid":false,"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, USF Health Byrd Alzheimer\u2019s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA"},{"name":"Institute for Biological Instrumentation of the Russian Academy of Sciences, Federal Research Center \u201cPushchino Scientific Center for Biological Research of the Russian Academy of Sciences\u201d, Pushchino, Moscow Region 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2325-5271","authenticated-orcid":false,"given":"Young Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science and Technology, Department of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5848-3338","authenticated-orcid":false,"given":"Chul Geun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Korea"},{"name":"Research Institute for Natural Sciences, Hanyang University, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/ehm.10.62","article-title":"Acute erythroleukemia: Diagnosis and management","volume":"3","author":"Santos","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","article-title":"Erythroleukemia-historical perspectives and recent advances in diagnosis and management","volume":"32","author":"Boddu","year":"2018","journal-title":"Blood Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.24626","article-title":"Pure erythroid leukemia","volume":"92","author":"Wang","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1749-6632.1987.tb36252.x","article-title":"Induction of transformed cells to terminal differentiation","volume":"511","author":"Marks","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/2011042a0","article-title":"Mouse Erythroleukemia of Viral Etiology","volume":"201","author":"Siegel","year":"1964","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1093\/nar\/gky193","article-title":"Mbd2-CP2c loop drives adult-type globin gene expression and definitive erythropoiesis","volume":"46","author":"Kim","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_8","first-page":"3215","article-title":"Identification and characterization of multiple erythroid cell proteins that interact with the promoter of the murine alpha-globin gene","volume":"8","author":"Barnhart","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"ref_9","first-page":"4270","article-title":"Purification of multiple erythroid cell proteins that bind the promoter of the alpha-globin gene","volume":"8","author":"Kim","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"ref_10","first-page":"5958","article-title":"Promoter elements and erythroid cell nuclear factors that regulate alpha-globin gene transcription in vitro","volume":"10","author":"Kim","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1016-8478(23)25235-8","article-title":"CP2 binding to the promoter is essential for the enhanced transcription of globin genes in erythroid cells","volume":"15","author":"Chae","year":"2003","journal-title":"Mol. Cells"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/bbrc.1999.1408","article-title":"Transcription factor CP2 is crucial in hemoglobin synthesis during erythroid terminal differentiation in vitro","volume":"263","author":"Chae","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1093\/nar\/gkq286","article-title":"PIAS1 regulates CP2c localization and active promoter complex formation in erythroid cell-specific alpha-globin expression","volume":"38","author":"Kang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1128\/MCB.25.14.6005-6020.2005","article-title":"Erythroid cell-specific alpha-globin gene regulation by the CP2 transcription factor family","volume":"25","author":"Kang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/febs.12972","article-title":"Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics","volume":"282","author":"Kloet","year":"2015","journal-title":"FEBS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/nar\/gkv168","article-title":"An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex","volume":"43","author":"Desai","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.1015341108","article-title":"p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex","volume":"108","author":"Gnanapragasam","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kim, M.Y., Na, I., Kim, J.S., Son, S.H., Choi, S., Lee, S.E., Kim, J.H., Jang, K., Alterovitz, G., and Chen, Y. (2019). Rational discovery of anti-metastatic agents targeting the intrinsically disordered region of MBD2. Sci. Adv., in press.","DOI":"10.1126\/sciadv.aav9810"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.biomaterials.2016.11.016","article-title":"Periosteum tissue engineering in an orthotopic in vivo platform","volume":"121","author":"Baldwin","year":"2017","journal-title":"Biomaterials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/2159-8290.CD-15-1336","article-title":"Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma","volume":"6","author":"Girotti","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10585-014-9638-5","article-title":"A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone","volume":"31","author":"Hesami","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biomaterials.2015.04.057","article-title":"Tissue engineered humanized bone supports human hematopoiesis in vivo","volume":"61","author":"Holzapfel","year":"2015","journal-title":"Biomaterials"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.15252\/emmm.201404914","article-title":"Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts","volume":"7","author":"Kemper","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1158\/1078-0432.CCR-15-1762","article-title":"Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies","volume":"22","author":"Krepler","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"39582","DOI":"10.18632\/oncotarget.8659","article-title":"The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer","volume":"7","author":"Suri","year":"2016","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2106\/JBJS.15.00920","article-title":"A Validated Preclinical Animal Model for Primary Bone Tumor Research","volume":"98","author":"Wagner","year":"2016","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/458290a","article-title":"Cancer: The nuances of therapy","volume":"458","author":"Ellis","year":"2009","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tibtech.2017.12.001","article-title":"Rational Design of Mouse Models for Cancer Research","volume":"36","author":"Landgraf","year":"2018","journal-title":"Trends Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"dmm033084","DOI":"10.1242\/dmm.033084","article-title":"Animal models for bone tissue engineering and modelling disease","volume":"11","author":"McGovern","year":"2018","journal-title":"Dis. Model Mech."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pascale, R.M., Simile, M.M., Peitta, G., Seddaiu, M.A., Feo, F., and Calvisi, D.F. (2019). Experimental Models to Define the Genetic Predisposition to Liver Cancer. Cancers, 11.","DOI":"10.3390\/cancers11101450"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","article-title":"Preclinical research: Make mouse studies work","volume":"507","author":"Perrin","year":"2014","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ncb437","article-title":"The mouse ascending: Perspectives for human-disease models","volume":"9","author":"Rosenthal","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrc3206","article-title":"Mouse models of cancer: Does the strain matter?","volume":"12","author":"Hunter","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrg3786","article-title":"The contribution of genetic variants to disease depends on the ruler","volume":"15","author":"Witte","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/0975-1483.66810","article-title":"TGN1412: From Discovery to Disaster","volume":"2","author":"Attarwala","year":"2010","journal-title":"J. Young Pharm."},{"key":"ref_40","first-page":"229","article-title":"Why drugs fail: Of mice and men revisited","volume":"7","author":"Takimoto","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(03)01139-2","article-title":"Why did p53 gene therapy fail in ovarian cancer?","volume":"4","author":"Zeimet","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_42","first-page":"215","article-title":"Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison","volume":"1826","author":"Calvisi","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/hep.22374","article-title":"Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus","volume":"48","author":"Manenti","year":"2008","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/genetics\/160.4.1609","article-title":"Simultaneous detection and fine mapping of quantitative trait loci in mice using heterogeneous stocks","volume":"160","author":"Mott","year":"2002","journal-title":"Genetics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.23488","article-title":"Progenitor-derived hepatocellular carcinoma model in the rat","volume":"51","author":"Andersen","year":"2010","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13402-011-0067-z","article-title":"An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis","volume":"35","author":"Frau","year":"2012","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nprot.2017.002","article-title":"Engineering a humanized bone organ model in mice to study bone metastases","volume":"12","author":"Martine","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.4103","article-title":"A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells","volume":"22","author":"Reinisch","year":"2016","journal-title":"Nat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bankert, R.B., Balu-Iyer, S.V., Odunsi, K., Shultz, L.D., Kelleher, R.J., Barnas, J.L., Simpson-Abelson, M., Parsons, R., and Yokota, S.J. (2011). Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024420"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yexcr.2015.07.020","article-title":"Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer","volume":"337","author":"Chu","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10911-016-9361-8","article-title":"Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis","volume":"21","author":"Eyre","year":"2016","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2011-08-376426","article-title":"Recruitment of monocytes\/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice","volume":"119","author":"Ferjancic","year":"2012","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fonc.2014.00026","article-title":"Recent technological advances in using mouse models to study ovarian cancer","volume":"4","author":"House","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fonc.2017.00219","article-title":"Models of Models: A Translational Route for Cancer Treatment and Drug Development","volume":"7","author":"Ogilvie","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Burghoff, S., Gong, X., Viethen, C., Jacoby, C., Flogel, U., Bongardt, S., Schorr, A., Hippe, A., Homey, B., and Schrader, J. (2014). Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-898"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood-2010-08-302240","article-title":"Diminished metastasis in tetraspanin CD151-knockout mice","volume":"118","author":"Takeda","year":"2011","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-08-4210","article-title":"A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro","volume":"69","author":"Daniel","year":"2009","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_60","first-page":"1125","article-title":"Influence of the site of tumor growth on the capacity of a low tumorigenic line of Friend erythroleukemia cells to differentiate","volume":"138","author":"Gresser","year":"1991","journal-title":"Am. J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yoon, Y., Lee, J., Ra, M., Gwon, H., Lee, S., Kim, M.Y., Yoo, K.C., Sul, O., Kim, C.G., and Kim, W.Y. (2019). Continuous Separation of Circulating Tumor Cells from Whole Blood Using a Slanted Weir Microfluidic Device. Cancers, 11.","DOI":"10.3390\/cancers11020200"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/11\/1707\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:19Z","timestamp":1760189479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/11\/1707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["cancers11111707"],"URL":"https:\/\/doi.org\/10.3390\/cancers11111707","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}